Research Development Office (RDO) Resources
The Research Development Office (RDO) is home to the Resource Allocation Program (RAP), which manages the dissemination, submission, review and award of various intramural funding opportunities, and the Limited Submission Program (LSP), which manages the dissemination, solicitation and selection of proposals for limited submission funding opportunities.
COVID Related Funding Opportunities
COVID Related Funding Opportunities (Searchable List)
Related NIH Notices
- NCI - NOT-CA-20-054 Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be redirected to COVID-19-Related Research During the Crisis
- NIBIB - NIH POCTRN - Fast-Track Program for COVID-19 Test Development and Distribution Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing Rolling Submission from April 29, 2020 until further notice
COVID 19 Supplements and Funded Extensions
NIH IC | COVID NOSI | PA(s) Used | Noted Requirements | Deadline | Release | Expires |
---|---|---|---|---|---|---|
NIDA |
NOT-DA-22-002 |
NIDA seeks to support research in addressing SARS-CoV-2 vaccine implementation among populations with current substance use and substance use disorders. |
Varies | 1/20/22 | ||
NIAAA | NOT-AA-22-002 | All active grant mechanisms and cooperative agreements are eligible, except the F’s, T’s, R13’s and L’s | Rolling basis begining 12/31/21 | 12/2/21 | 5/8/24 | |
NCATS | NOT-TR-21-017 | PA-20-272 | Supplements PAR-18-940, PAR-18-464, PAR-15-304, RFA-TR-14-009, RFA-TR-17-006, RFA-TR-16-021, RFA-TR-15-002 and RFA-TR-15-004 | Rolling Basis 1/28/21-8/16/24 |
2/3/21 | 8/17/24 |
NEI | NOT-EY-22-010 |
|
Due dates on/after 3/7/22 - 3/9/24 | 2/4/22 | 3/9/24 | |
NICHD, NIAAA, NIDA, NINDS, OBSSR, ORWH |
Applicants are strongly encouraged to notify the program contact at the Institute supporting the parent award that a request has been submitted in response to this FOA in order to facilitate efficient processing of the request. Training and REDCap Demonstration on 11/1/22. Registration is required. |
Due dates on/after 4/29/22 | 4/19/22 | 6/6/24 | ||
NCI, ORWH, NEI, NHLBI, NHGRI,NIA, |
|
This initiative does NOT use the streamlined submission process through eRA Commons. |
1/6/23 |
12/2/21 | 1/27/23 | |
ORWH, NEI, NHLBI, NHGRI,NIA, NIAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH,NINDS, NINR, NCCIH, SGMRO, NCI, ONR |
NOT-OD-22-208 | Only PDs/PIs of an active DP1, DP2, DP4, DP5, K01, K08, K23, K76, K99/R00, P01, P20, P30, P40, P41, P50, P51, P60, P2C, PM1, R01, R03, R15, R21, R24, R25, R33, R34, R35, R37, R41/R42, R43/R44, R41, R42, R43, R44, RC4, RM1, S06, S11, U01, U10, U19, U2C, U42, U44, U54, U56, UC2, UL1, UM1, UM2, UG1, UG3/UH3, UH2/UH3, UH2, or UP5 award from NIH are eligible |
1/31/23 |
9/7/22 | 2/1/23 | |
ORWH, NIA, NIAID, NIDA, NIMHD, NLM, SGMRO, NCI |
NOT-OD-23-029 |
Specific aims added to the parent grant per SARS-CoV-2/COVID-19 Competitive Revisions process are considered as part of the parent application and are eligible. The parent peer-reviewed NIH funded grant must have at least 16 months of active grant support remaining from the due date. No-cost-extension is not an eligibility criterion. An exception may be given for proposals studying SARS-CoV-2 or COVID-19, please contact the ORWH scientific contact for approval |
2/13/23 | 12/5/22 | 3/1/23 | |
OD, NEI, NHLBI, NHGRI, NIA, NIAAA, NIAID,NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK,NIDA, NIEHS, NIMH, NINDS, NINR, NIMHD,NLM, FIC, NCCIH, NCATS, NCI, ORWH, ODSS, SGMRO, THRO |
NOT-OD-23-018 | Applicants are strongly encouraged to notify the program contact at the NIH Institute or Center supporting the parent award that a request has been submitted in response to this FOA in order to facilitate efficient processing of the request. | 2/17/23 | 11/17/22 | 2/17/23 | |
ODSS, NIA, NICHD, NIDCR, NIDA, NIMH, NINR, NIMHD, NLM |
NOT-OD-23-041 | This announcement is for supplements to existing RADx parent projects | 2/20/23 | 12/19/22 | 2/20/23 |
Sponsor/Topic-Specific Guidance and Policy